Related stories
NiCE Exceeds Revenue and EPS Guidance Ranges, Raises Full-Year EPS Guidance
NiCE reported 8% year-over-year revenue growth in the third quarter of 2026. AI ARR reached $392 million, up 46% year over year.
M impact | EARNINGS | Nov 04, 2026, 10:42 AM UTC
Novo Posts 14% Profit Growth Through September, Raises Annual Forecast
Danish pharmaceutical company Novo reported profit growth of 14% through September and raised its annual forecasts.
M impact | EARNINGS | Nov 04, 2026, 10:33 AM UTC
NICE Reports Q3 Gross Margin of 62.4%
L impact | EARNINGS | Nov 04, 2026, 10:31 AM UTC
NiCE Q3 Net Income Falls 34% to $95.08 Million
M impact | EARNINGS | Nov 04, 2026, 10:31 AM UTC
NICE Posts Q3 Adjusted EPS of $2.84 per Share
NICE reported Q3 adjusted EPS of $2.84 per share, versus a FactSet estimate of $2.78.
M impact | EARNINGS | Nov 04, 2026, 10:30 AM UTC
NICE Reports Q3 Net Income of $95.1 Million
L impact | EARNINGS | Nov 04, 2026, 10:30 AM UTC